After 15 Years of Failures, Cancer Drug Shows Real Promise
A biotech company just achieved what industry giants couldn't for 15 years: making a promising cancer immunotherapy targeting OX40 actually work. The breakthrough offers new hope for patients with certain head and neck cancers.